Earlier Detection May Be Key to Treatment Advances in Chronic GVHD

摘要

Systemic management of chronic graft-versus-host disease (GVHD) can be an ongoing battle in patients with cancer, with the goals of approved treatments including improvement of quality of life.In an OncView conversation with CancerNetwork~R, Yi-Bin Chen, MD, director of the Blood & Marrow Transplant Program at Massachusetts General Hospital, Cara J. Rogers Endowed Scholar, and associate professor of medicine at Harvard Medical School in Boston, Massachusetts, discussed GVHD diagnosis and recent advances in treating the disease.